arrow
N

Nikolaos Gatselis

general university hospital of larissa
H指数:42
被引数:7,088

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Statins are associated with decreased risk of disease progression and death in non-cirrhotic patients with primary biliary cholangitis

他汀类药物与非肝硬化原发性胆汁性胆管病患者疾病进展和死亡风险降低相关

2026-10-030
PRE
Declining but persistent hepatocellular cancer risk beyond 10 years of entecavir or tenofovir in chronic hepatitis B: Results of the PAGE-B cohort

在慢性乙型肝炎中,恩替卡韦或替诺福韦治疗10年后肝癌风险下降但仍持续存在:PAGE-B队列研究结果

2026-07-060
OAAI
Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis

肝硬度测量的预后价值与生化反应在原发性胆汁性胆管炎中的比较

2025-10-030
PRE
R202Q homozygosity of Mediterranean fever gene is associated with atypical clinical phenotype of familial Mediterranean fever

Mediterranean fever基因的R202Q纯合子与家族性地中海热的不典型临床表型相关。

2025-03-220
PRE
Fibrate-Oca (FI-OCA) Study-a Global snapshot of PBC practice around the Globe
2025-03-010
PRE
Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis

肝脏硬度测量的动力学和原发性胆汁性胆管炎的临床过程

2024-12-011
OAAI
Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma
2024-11-011
OAAI
Unmet needs in autoimmune hepatitis: Results of the prospective multicentre European Reference Network Registry (R-LIVER)

自身免疫性肝炎的未满足需求: 前瞻性多中心欧洲参考网络注册 (r-liver) 的结果

2024-07-224
OAAI
Calprotectin serum levels on admission and during follow-up predict severity and outcome of patients with COVID-19: A prospective study
2024-04-011
PRE
Longer transplant-free and liver-related event-free survival in obeticholic acid-treated patients with primary biliary cholangitis compared to external controls from two large real-world cohorts
2024-02-011
PRE
Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): Results from a large multicentre study of the International AIH Group
2023-10-014
OAAI
Innate Immune Gene Polymorphisms and COVID-19 Prognosis
2023-08-225
OAAI
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?

在原发性胆汁性胆管炎中对熊去氧胆酸的充分反应与深度反应: 正常碱性磷酸酶水平在多大程度上和在什么条件下与无并发症生存率增加相关?

2023-07-0323
OA
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival
2023-05-0810
OAAI
Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: a subgroup analysis of the SAVE-MORE randomised trial
2023-02-0113
OAAI